In Utero Exposure to Antipsychotics
May 2011, ObGyn News, Lee S. Cohen, MD
New FDA Warning on the Use of Antipsychotic Medications in Pregnancy
On February 22, 2011, the U.S. Food and Drug Administration (FDA) informed healthcare professionals that drug labels for the entire class of antipsychotic drugs have been updated to include warnings regarding the use of antipsychotic drugs during pregnancy. The new drug labels now contain more details on the potential risk for abnormal muscle movements (extrapyramidal signs or EPS) and withdrawal symptoms in newborns exposed to these drugs during the third trimester of pregnancy.